MARKETSSun Pharma ILUMYA Gets USFDA Nod for Psoriatic Arthritis Tabassum ChaudharyOctober 30, 2026October 30, 2026 October 30, 2026October 30, 2026 Sun Pharma touched a day high of Rs 1,802.40 on 30 October after the US FDA approved its drug ILUMYA for adults with psoriatic arthritis....